Satellite Bio CEO Dave Lennon and co-founder Sangeeta Bhatia
April 20, 2022 07:30 AM EDTUpdated 10:53 AM
Financing
Startups
Cell/Gene Tx

Wel­come to 'tis­sue ther­a­peu­tics’: Dave Lennon’s $110M new ven­ture will im­plant ‘hap­py cells’ that ‘sur­vive and thrive’

Kyle LaHucik

Senior Reporter

You’ve heard of cell ther­a­pies. You’ve cer­tain­ly heard of gene ther­a­pies. But have you heard of tis­sue ther­a­peu­tics?

Just in time for May flow­ers, a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times